Markets › India › NSE › SAILIFE

Sai Life Sciences Ltd

NSE:SAILIFEHealthcareNSE:CNX500NSE:CNXPHARMA

₹1,395.90+0.47%At closeAt close · Mon 19 Oct · ≈ AED 53.86 · Market cap $3.13B · Next earnings Thu 5 Nov

INR billions	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Net income	—	—	—	—	2.3	3.5	+53.2%
Depreciation & amortization	—	0.9	1.0	1.2	1.4	1.7	+20.4%
Stock-based compensation	—	—	—	—	0.0	0.0	−15.1%
Change in working capital	—	(0.2)	0.3	(0.4)	(1.3)	(0.7)	+43.7%
Operating cash flow	—	0.7	1.7	2.2	2.8	5.2	+87.7%
Capital expenditure	—	(2.1)	(1.1)	(1.8)	(3.7)	(5.9)	−60.6%
Acquisitions	—	—	—	—	(0.0)	0.0	+790.7%
Investing cash flow	—	—	—	—	(5.5)	(4.2)	+24.4%
Dividends paid	—	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	—	—	—	—	0.0	0.0	—
Debt issued / repaid	—	—	—	—	(5.7)	(0.3)	+94.1%
Financing cash flow	—	—	—	—	3.5	(1.1)	−131.9%
Free cash flow	(1.3)	(1.3)	0.6	0.3	(0.9)	(0.7)	+21.5%
Net change in cash	—	—	—	—	1.9	(1.1)	−160.9%